ART SHARE 003 launches the initial offering of the iconic artwork ‘Abstraktes Bild (809-4)’ by Gerhard Richter.
September 18, 2024 01:31 ET
|
Art Share 003
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR...
YHN Acquisition I Limited Announces Pricing of $60,000,000 Initial Public Offering
September 17, 2024 17:00 ET
|
YHN Acquisition I Limited
New York, NY, Sept. 17, 2024 (GLOBE NEWSWIRE) -- YHN Acquisition I Limited (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The units...
Kairos Pharma Closing of $6.2 Million Initial Public Offering
September 17, 2024 16:29 ET
|
Kairos Pharma, Ltd.
LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”) (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer...
Impact BioMedical Inc. Announces the Closing of its Initial Public Offering
September 17, 2024 11:29 ET
|
Impact BioMedical, Inc.
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced the...
Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
September 16, 2024 16:01 ET
|
Bicara Therapeutics Inc.
BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies for...
Kairos Pharma Prices $6.2 Million Initial Public Offering
September 16, 2024 10:49 ET
|
Kairos Pharma, Ltd.
LOS ANGELES, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”), a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse...
Impact BioMedical Inc. Announces Pricing of Initial Public Offering
September 16, 2024 10:24 ET
|
Impact BioMedical, Inc.
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the...
Veea Inc. and Plum Acquisition Corp. I Announce Closing of Business Combination
September 16, 2024 08:30 ET
|
Veea Inc.
NEW YORK and SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Veea Inc. (“Veea” or the “Company”), a first-to-market pioneer in hyperconverged multiaccess networks and AI-driven edge computing, and...
Prairie Provident Announces Loan Amendments and $13.2 Million Equity Rights Offering With $12 Million of Committed Participation
September 13, 2024 19:13 ET
|
Prairie Provident Resources Inc.
CALGARY, Alberta, Sept. 13, 2024 (GLOBE NEWSWIRE) -- September 13, 2024 – Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) announces an agreement to extend the...
Future Vision II Acquisition Corp. Announces the Closing of its Initial Public Offering and Full Exercise of Underwriter’s Over-Allotment Option to Purchase Additional Units
September 13, 2024 12:31 ET
|
FUTURE VISION II ACQUISITION CORP.
NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Future Vision II Acquisition Corp. (NASDAQ: FVNNU) (“Future Vision”) today announced the closing of its initial public offering of 5,750,000 units,...